In ovarian cancer (OVCA), amplified USP13 promoted core metabolic pathways by stabilizing ACLY and OGDH, providing enough ATP, reducing equivalents, and precursors for lipid biosynthesis for OVCA cell growth (Han et al., 2016). Here, USP13 is linked to ovarian cancer.